  | |
| Published | : | | | | Books | : | Name：特定標的之新藥開發: 第九章 臨床前藥物動力學試驗 (2005)
Authors：林君榮
| | Posters & Speeches | : | Subjects：Enhancement of dissolution rate and oral bioavailability of lovastatin in red yeast rice products (2014)
Speakers：Chia-Hao Chen, Jyh-Chin Yang, Yow-Shieng Uang, Chun-Jung Lin
Address：5th FIP Pharmaceutical Sciences World Congress (PWSC), Melbourne, Australia
Subjects：The interaction between human PMAT and N-methyl-(R)SAL/1-benzyl-TIQ (2013)
Speakers：Kuo-Chen Wu, Yi-Hsuan Peng, Ya-Hsuan Lu, Chun-Jung Lin
Address：The 11th International Conference On Alzheimer’s & Parkinson’s Disease. Firenze, Italy
Subjects：Pharmacokinetic/pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter Pylori (2012)
Speakers：Yu-Fan Yang, Jyh-Chin Yang, Yow-Shieng Uang, Chun-Jung Lin
Address：World Conference on Pharmacometrics, Seoul, Korea
Subjects：The effects of Chinese red yeast rice on the activities of CYP450 enzymes and P-glycoprotein and the pharmacokinetic study of LipoCol Forte® in healthy volunteers. (2011)
Speakers：Chia-Hao Chen, Jyh-Chin Yang, Yow-Shieng Uang, Shang-Ta Wang, Chun-Jung Lin
Address：AAPS annual meeting at Walter E. Washington Convention Center, Washington, DC, USA
Subjects：The PKC-mediated down-regulation of P-glycoprotein expression under high glucose condition in MDCK II cells (2011)
Speakers：Szu-Yu Yeh, Chung-Cheng Lin, Chun-Jung Lin
Address：Bethesda AAPS (American Association of Pharmaceutical Scientists) Workshop, Bethesda North Marriott Conference Center, Bethesda, MD, USA.
Subjects：High Cumulative Eradication rate in the First-line and Rescue therapy for Helicobacter pylori infection by Repeated High dose dual therapy (2015)
Speakers：Jyh-Chin Yang, Chun-Jung Lin, Jin-De Chen et al.
Address：Digestive Disease Week (DDW), Washington, D.C. 20001, United States
Subjects：Effect of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at brain microvessels and the brain concentrations of 1-benzyl-1, 2, 3, 4-tetrahydroisoquinoline in C57BL/6 mice (2015)
Speakers：Kuo-Chen Wu, Ya-Hsuan Lu, Chun-Jung Lin
Address：7th Asian Association of School of Pharmacy (AASP) meeting, Taipei, Taiwan
Subjects：Increased P-glycoprotein expression in brain capillaries of Huntington’s disease transgenic mice and patients. (2016)
Speakers：Kao YH, Chern Y, Yang HT, Chen HM, Lin CJ
Address：11th Annual Huntington\'s disease therapeutics conference Palm Springs, CA, USA
Subjects：Genotypic testing is suboptimal to predict antibiotic resistance and therapeutic outcome for Helicobacter pylori eradication in clinical practice (2016)
Speakers：Jyh-Chin Yang, Chun-Jung Lin, Huei-Mi Li et al.
Address：Digestive Disease Week (DDW) San Diego, California, USA
Subjects：Changes in the pharmacokinetics of fluvastatin, atorvastatin, and simvastatin but not of rosuvastatin and pravastatin in collagen-induced arthritis rats (2017)
Speakers：Chun-Han Lin, Ke-Wei Hsu, Chia-Hao Chen, Yow-Shieng Uang, Chun-Jung Lin
Address：6th FIP Pharmaceutical Sciences World Congress (PSWC) Stockholm, Sweden
Subjects：Brain homeostasis of α-synuclein differs in mice with and without functional Nramp1 under PD-related pathological conditions (2018)
Speakers：Kuo-Chen Wu, Chun-Jung Lin
Address：International conference on Alzheimer’s disease & Dementia, Tokyo, Japan
Subjects：The role of equilibrative nucleoside transporter-2 in the modulation of neuroinflammation (2018)
Speakers：Chih-Yu Lee, Kuo-Chen Wu, Yu-Han Kao, Chun-Jung Lin
Address：2018 Society for Neurosciences annual meeting, San Diego, USA
Subjects：The role of equilibrative nucleoside transporter-2 on the amelioration of acute lipopolysaccharide-induced breakdown of the blood-brain barrier (2019)
Speakers：Kuo-Chen Wu, Chun-Jung Lin
Address：Brain & brain PET 2019 (Yokohama, Japan)
Subjects：Roles of equilibrative nucleoside transporter-2 in energy homeostasis in the striatum of mice (2022)
Speakers：C.-J. HO1, C.-Y. CHEN1, K.-C. WU1, Y. CHERN2, C.-J. LIN
Address：SfN (USA)
Subjects：Inhibition of equilibrative nucleoside transporter 1 (ENT1) inhibitor as a novel therapeutic treatment to rescue Alzheimer’s disease pathology and cognitive impairment (2022)
Speakers：Ching-Wen Wu, Ching-Pang Chang, Chien-Yu Lin, Kuo-Chen Wu, Hsin-Hsien Yeh, Chun-Jung Lin, Yijuang Chern
Address：CTAD (USA)
| | Research Projects | : | Subject：The role of neurodegenerative dseases on the transport of nucleoside drugs across the blood-brain barrier
Duration：2011-05 ~ 2014-04
Principal Investigator：Chun-Jung Lin
Subject：The investigation of the role of SLC11A1 on the degradation of alpha-synuclein and its implication to alpha-synuclein-induced neurotoxicity
Duration：2016-08 ~ 2017-07
Principal Investigator：Chun-Jung Lin
Subject：Effects of rheumatoid arthritis on the expression of CYP450 enzymes and transporters and its implications to the pharmacokinetics of statins
Duration：2015-08 ~ 2016-07
Principal Investigator：Chun-Jung Lin
Subject：Targeting brain adenosine homeostasis for the treatment of Huntington’s disease
Duration：2015-01 ~ 2015-12
Principal Investigator：Chun-Jung Lin
Subject：The roles of neurons and astrocytes in the modulation of adenosine and adenine nucleotides in the brain of Huntington\\\'s disease
Duration：2017-01 ~ 2017-12
Principal Investigator：Chun-Jung Lin
Subject：The implications of ENT2 in the modulation of neuroinflammation and disease progression in Huntington\\\'s disease
Duration：2018-08 ~ 2021-07
Principal Investigator：Chun-Jung Lin
Subject：The effects of rheumatoid arthritis and the treatment of nonsteroidal anti-inflammatory drugs on the regulation of the blood-brain barrier and its implications to the transport of beta-amyloid
Duration：2017-08 ~ 2020-07
Principal Investigator：Chun-Jung Lin
Subject：The investigation of the roles of equilibrative nucleoside transporters on pathological response and disease progression of ischemic stroke and ischemia-reperfusion injury
Duration：2021-08 ~ 2024-07
Subject：Treatment of Alzheimer's disease by overcoming energy crisis
Duration：2021-01 ~ 2024-12
Subject：The investigation of the roles of brain adenosine homeostasis on the pathogenesis and treatment of Parkinson's disease
Duration：2020-08 ~ 2021-07
Principal Investigator：Chun-Jung Lin
|
|
